Public Health Genomics Evidence-Based Programs Listing | Evidence-Based Cancer Control Programs (EBCCP)

Program Title & Description	Program Area	Population Focus	Delivery Location	Community Type	Age	Age	Sex	Race/Ethnicity	Origination	Materials	Purpose	Program URL
Breast Cancer Risk & Genetic Testing Criteria Matched: Public Health Genomics	Informed Decision Making, Public Health Genomics		Clinical	Suburban, Urban/Inner City	19-39 Years (Young Adults), 40-65 Years (Adults), 65+ Years (Older Adults)	19-39 Years, 40-65 Years, 65+ Years	Female	Black (not of Hispanic or Latino Origin), Hispanic or Latino, White (not of Hispanic or Latino Origin)	United States	Available from Third Party Only	Designed to enhance knowledge in the decision making process for genetic testing for breast cancer susceptibility.	https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=277363
Communication and Education in Tumor Profiling (COMET) Criteria Matched: Public Health Genomics	Public Health Genomics, Survivorship / Supportive Care	Cancer Survivors	Clinical, Home	Urban/Inner City	19-39 Years (Young Adults), 40-65 Years (Adults), 65+ Years (Older Adults)	19-39 Years, 40-65 Years, 65+ Years	Female, Male	Black (not of Hispanic or Latino Origin), Hispanic or Latino, White (not of Hispanic or Latino Origin)	United States	Available from Third Party Only	The program is designed to increase patients’ understanding of tumor genetic testing.	https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=35471150
Improving Knowledge, Risk Perception, and Risk Communication Among Colorectal Adenoma Patients Criteria Matched: Public Health Genomics	Public Health Genomics, Informed Decision Making		Clinical		19-39 Years (Young Adults), 40-65 Years (Adults), 65+ Years (Older Adults)	19-39 Years, 40-65 Years, 65+ Years	Female, Male	Black (not of Hispanic or Latino Origin), Hispanic or Latino, White (not of Hispanic or Latino Origin)	United States	Available on the Website	Designed to improve knowledge, risk perception, and risk communication among colorectal adenoma patients.	https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=1472737